DHA 4000 NPD1 + ASTAXANTINA
Food supplement declared in France, decision dated 7 November 2026
DHA 4000 NPD1 + ASTAXANTINA (EGLÉ) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- EGLÉ
- Food business operator placing the product on the market
- LABORATORIO EGLÉ INTERNACIONAL, S.L
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 1 flacon par jour
- Directions for use
- Prendre un flacon par jour, de préférence au moment des repas
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Children (under 12)
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant, Arteries and cholesterol, Blood and lymphatic circulation, Concentration, Immunity, Memory, Skin, Nervous system
Declaration 381729, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Oléorésine riche en astaxanthine extraite de l’algue Haematococcus pluvialis | not declared |
| Huile de poisson | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-alpha-tocophérol | Vitamine E | 300 mg | 30 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires ne soient utilisés comme substituts d'un régime alimentaire varié. Il est nécessaire de maintenir une alimentation variée et équilibrée et un mode de vie sain. Ne pas dépasser la dose journalière expressément recommandée. Les produits doivent être tenus hors de la portée des jeunes enfants. Ce produit ne doit pas être consommé par les nourrissons, les enfants ni les adolescents de moins de 14 ans. Avec le temps, le produit peut présenter de légères variations d'aspect ou de goût, qui n'affectent en rien sa qualité. Agiter avant consommation. Conserver dans un endroit sec, frais et à l'abri de la lumière directe. Ne pas dépasser un apport quotidien supplémentaire de 5 g d'EPA et de DHA combinés. Ce produit ne doit pas être consommé si d'autres compléments alimentaires contenant des esters d'astaxanthine sont consommés le même jour.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : EGLÉ
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.